Osimertinib study in Indian Patients

Trial Identifier:	D5161C00005
Sponsor:	AstraZeneca
NCTID::	NCT03853551
Start Date:	April 2019
Primary Completion Date:	April 2020
Study Completion Date:	April 2020
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
India	Hyderabad, India, 500096
India	Hyderabad, India, 500034
India	Kolkata, India, 700160
India	Mumbai, India, 400053
India	Mumbai, India, 400012
India	New Dehli, India, 110029
India	New Delhi, India, 110085

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.